Timmermans S, Wallaeys C, De Beul S, Garcia-Gonzales N, Libert C
Front Immunol. 2025; 16:1543059.
PMID: 39981239
PMC: 11840258.
DOI: 10.3389/fimmu.2025.1543059.
Chitkara P, Singh A, Gangwar R, Bhardwaj R, Zahra S, Arora S
BMC Plant Biol. 2024; 24(1):1162.
PMID: 39627690
PMC: 11616359.
DOI: 10.1186/s12870-024-05900-0.
Arya A, Arora S, Hamid F, Kumar S
3 Biotech. 2024; 14(11):282.
PMID: 39479298
PMC: 11519250.
DOI: 10.1007/s13205-024-04132-1.
Kim S, Kim N, Choi Y, Lee S, Choi J, Shin S
Cancers (Basel). 2024; 16(13).
PMID: 39001529
PMC: 11240350.
DOI: 10.3390/cancers16132467.
Mohammad T, Zolotovskaia M, Suntsova M, Buzdin A
Front Oncol. 2024; 14:1415801.
PMID: 38919532
PMC: 11196610.
DOI: 10.3389/fonc.2024.1415801.
Sex-Biased Transcription Expression of Vitellogenins Reveals Fusion Gene and MicroRNA Regulation in the Sea Louse Caligus rogercresseyi.
Casuso A, Benavente B, Leal Y, Carrera-Naipil C, Valenzuela-Munoz V, Gallardo-Escarate C
Mar Biotechnol (NY). 2024; 26(2):243-260.
PMID: 38294574
DOI: 10.1007/s10126-024-10291-2.
Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer.
Sanchez-Marin D, Silva-Cazares M, Porras-Reyes F, Garcia-Roman R, Campos-Parra A
Genes Dis. 2024; 11(3):101136.
PMID: 38292185
PMC: 10825296.
DOI: 10.1016/j.gendis.2023.101136.
Progressive insights into fibrosarcoma diagnosis and treatment: leveraging fusion genes for advancements.
Tang X, Hu X, Wen Y, Min L
Front Cell Dev Biol. 2023; 11:1284428.
PMID: 37920823
PMC: 10618559.
DOI: 10.3389/fcell.2023.1284428.
RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities.
Srivastava A, Rikhari D, Srivastava S
Genes Dis. 2023; 11(2):788-806.
PMID: 37692504
PMC: 10491879.
DOI: 10.1016/j.gendis.2023.01.013.
ChimeraTE: a pipeline to detect chimeric transcripts derived from genes and transposable elements.
Oliveira D, Fablet M, Larue A, Vallier A, Carareto C, Rebollo R
Nucleic Acids Res. 2023; 51(18):9764-9784.
PMID: 37615575
PMC: 10570057.
DOI: 10.1093/nar/gkad671.
Molecular characterization of genomic breakpoints of ALK rearrangements in non-small cell lung cancer.
Wang Z, Han Y, Tao H, Xu M, Liu Z, Zhu J
Mol Oncol. 2022; 17(5):765-778.
PMID: 36423218
PMC: 10158786.
DOI: 10.1002/1878-0261.13348.
Novel gene-intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy.
Cutrupi A, Narayanan R, Perez-Siles G, Grosz B, Lai K, Boyling A
Brain. 2022; 146(3):880-897.
PMID: 36380488
PMC: 9976978.
DOI: 10.1093/brain/awac424.
Novel read-through fusion transcript Bcl2l2-Pabpn1 in glioblastoma cells.
Zhang L, Wang D, Han X, Guo X, Cao Y, Xia Y
J Cell Mol Med. 2022; 26(17):4686-4697.
PMID: 35894779
PMC: 9443946.
DOI: 10.1111/jcmm.17481.
Fusion Genes in Prostate Cancer: A Comparison in Men of African and European Descent.
Morgan R, Keeley D, Hazard E, Allott E, Wolf B, Savage S
Biology (Basel). 2022; 11(5).
PMID: 35625354
PMC: 9137560.
DOI: 10.3390/biology11050625.
Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer.
Li W, Wan R, Guo L, Chang G, Jiang D, Meng L
BMC Med. 2022; 20(1):160.
PMID: 35534835
PMC: 9087946.
DOI: 10.1186/s12916-022-02362-9.
Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data.
Hoogstrate Y, Komor M, Bottcher R, van Riet J, van de Werken H, van Lieshout S
Gigascience. 2021; 10(12).
PMID: 34891161
PMC: 8673554.
DOI: 10.1093/gigascience/giab080.
The Fusion of and Arises from a -Splicing Event in Normal and Transformed Human Cells.
Dhungel B, Monteuuis G, Giardina C, Tabar M, Feng Y, Metierre C
Int J Mol Sci. 2021; 22(22).
PMID: 34830054
PMC: 8625150.
DOI: 10.3390/ijms222212178.
Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer.
Wang M, Huang M, Wang C, Tang X, Wang J, Yang Y
Front Oncol. 2021; 11:682021.
PMID: 34211850
PMC: 8239224.
DOI: 10.3389/fonc.2021.682021.
RNAi technology targeting the fusion breakpoint: an opportunity for precision medicine.
Parker Kerrigan B, Ledbetter D, Kronowitz M, Phillips L, Gumin J, Hossain A
Neurooncol Adv. 2020; 2(1):vdaa132.
PMID: 33241214
PMC: 7680176.
DOI: 10.1093/noajnl/vdaa132.
Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers.
Chang F, Lin F, Cao K, Surrey L, Aplenc R, Bagatell R
J Mol Diagn. 2019; 21(5):873-883.
PMID: 31255796
PMC: 6734859.
DOI: 10.1016/j.jmoldx.2019.05.006.